Claims-based Validation of a UK COPD Clinical Risk Prediction Model

Lead UK Investigator: 

Daryl Freeman MBChB MRCGP, GP Principal Norfolk; Clinical Director NHS England- Midlands & East(East)

Research Team:Status: Planned Study, Seeking Funding

Support:

Registration:

Short Description:

The Respiratory Effectiveness Group has developed a risk prediction tool using routinely collected primary care data from the UK to identify patients at increased risk of multiple COPD exacerbations.

This study aims to:

  • Develop an equivalent model using administrative insurance claims data to identify patients at increased risk of multiple COPD exacerbations.
  • To test the external validity of the UK model by seeking to validate it in a non-UK (claims-based) healthcare setting.

Documents and Publications

Protocol

Abstracts

Presentations

Final Publications

Additional Material